Skip to main content
SpringerLink
Log in

ASO Author Reflections: Discordant Pathologic and Radiologic Response of Colorectal Liver Metastases After Chemotherapy: Which One Should We Trust to Predict Outcome and to Tailor Postoperative Chemotherapy?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Viganò L, Capussotti L, Barroso E, et al. Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol. 2012;19:2786–96.

    Article  Google Scholar 

  2. Brouquet A, Zimmitti G, Kopetz S, et al. Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases. Cancer. 2013;119:2778–88.

    Article  Google Scholar 

  3. Chun YS, Vauthey J-N, Boonsirikamchai P, et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009;302:2338–44.

    Article  CAS  Google Scholar 

  4. Brouquet A, Blot C, Allard MA, et al. What is the prognostic value of a discordant radiologic and pathologic response in patients undergoing resection of colorectal liver metastases after preoperative chemotherapy? Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08284-1

  5. Hosseini-Nik H, Fischer SE, Moulton C-AE, et al. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy. Abdom Radiol N Y. 2016;41:231–8.

Download references

Author information

Authors and Affiliations

  1. Service de Chirurgie Digestive et Oncologique, Hôpital Bicêtre – Hôpitaux Universitaires Paris Sud, 94275, Le Kremlin Bicetre, France

    Antoine Brouquet MD, PhD & Stephane Benoist MD, PhD

  2. Faculté de Médecine, Université Paris Sud, 94275, Le Kremlin Bicetre, France

    Antoine Brouquet MD, PhD & Stephane Benoist MD, PhD

Authors
  1. Antoine Brouquet MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephane Benoist MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antoine Brouquet MD, PhD.

Ethics declarations

Disclosure

Antoine Brouquet has received speaker’s fees from Takeda, Merck-Serono, Abbvie, Roche, Amgen, and Janssen-Cilag; and scientific meeting invitations from Biom’up, Eumedica, Nestlé, and Roche. Stephane Benoist has received board fees from Amgen and Biom’up; fees for oral presentations from Amgen, Roche, Merck Serrono, Nestlé, Servier, and Sanofi; and congress invitations from Biom’up, Merck, and Roche.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ASO Author Reflections is a brief invited commentary on the article “What is the prognostic value of a discordant radiologic and pathologic response in patients undergoing resection of colorectal liver metastases after preoperative chemotherapy?”, Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08284-1

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brouquet, A., Benoist, S. ASO Author Reflections: Discordant Pathologic and Radiologic Response of Colorectal Liver Metastases After Chemotherapy: Which One Should We Trust to Predict Outcome and to Tailor Postoperative Chemotherapy?. Ann Surg Oncol 27, 2886–2887 (2020). https://doi.org/10.1245/s10434-020-08338-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08338-4

Search

Navigation